SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Huaizhong Health Group, Inc. (ADAD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 16/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ADAD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.00 |
$0.00 |
$-72.00 |
- |
| 2014 |
$90.89 |
$91.31K |
$22.72K |
24.9% |
| 2015 |
$-153.15 |
$105.84K |
$-47.78K |
-45.1% |
| 2016 |
$2.46 |
$41.63K |
$866.00 |
2.1% |
| 2017 |
$-0.60 |
$40.51K |
$-78.13K |
-192.9% |
| 2018 |
$-0.02 |
$20.55K |
$-6.37K |
-31% |
| 2019 |
$-0.41 |
$20.55K |
$-126K |
-613% |
| 2020 |
$0.00 |
$0.00 |
$-36.48K |
- |
| 2021 |
$0.00 |
$0.00 |
$-30.83K |
- |
| 2022 |
$0.00 |
$0.00 |
$-29.17K |
- |
